Barres et al [42] reported altered promotor methylation of PDK4 in obese individuals, with the alteration being restored by significant weight loss, suggesting that empagliflozin protects against obesity-induced alterations in PDK4 expression upon WD feeding. This evidence concerns the gene PDK4 and obesity due to melanocortin 4 receptor deficiency.